Retrospective Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Jun 9, 2025; 14(2): 102049
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.102049
Table 1 Demographic and clinical characteristics of the study participants, n (%)
Variables
Total (n = 289)
Restricted parental care (n = 167)
Unrestricted parental care (n = 122)
P value
Age (years), median (IQR)5.6 (2.0-12.8)7.5 (2.8-13.7)3.5 (1.3-10.8)< 0.01
Sex, male134 (46.4)69 (41.3)65 (53.3)0.04
Weight (kg), median (IQR)17.4 (11-32.4)19.6 (12-39)15 (9.5-28.8)< 0.01
Comorbidities, yes37 (12.8)26 (15.)11 (9.0)0.10
Presence of cerebral palsy, yes13 (4.5)11 (6.7)2 (1.6)0.05
Type of surgery
Orthopedic134 (46.4)90 (53.9)44 (36.1)< 0.01
Abdominal91 (31.5)47 (28.1)44 (36.1)-
Other64 (22.1)30 (18.0)34 (27.8)-
LOS in ICU (days), median (IQR)2 (2-3)2 (2-3)2 (2-4)0.04
Hospital LOS, mean ± SD16.0 ± 6.514.6 ± 6.018.2 ± 6.5< 0.001
RASS, mean ± SD1.1 ± 0.31.2 ± 0.51.0 ± 0.2< 0.01
Received diazepam56 (19.4)45 (27.0)11 (9.0)< 0.001
Diazepam dose (mg/kg), median (IQR)0.1 (0.1-0.1)0.1 (0.1-0.1)0.1 (0.1-0.1)0.74
Received dexmedetomidine3 (1.0)1 (0.6)2 (1.6)0.58
Dexmedetomidine dose (mg/kg), median (IQR)0.7 (0.7-0.7)0.7 (0.7-0.7)0.7 (0.7-0.7)1.00
Received trimeperidine209 (72.3)133 (79.6)76 (62.3)< 0.01
Trimeperidine dose (mg/kg), median (IQR)0.2 (0.15-0.25)0.2 (0.2-0.25)0.2 (0.15-0.25)1.00
Received morphine86 (29.8)35 (21.0)51 (41.8)< 0.001
Morphine dose (mg/kg), median (IQR)0.1 (0.1-0.1)0.1 (0.1-0.1)0.1 (0.1-0.1)0.81
Table 2 Demographic and clinical characteristics by prescriptions for sedation therapy, n (%)
VariablesDiazepam
Trimeperidine
Morphine
Yes
No
Yes
No
Yes
No
Age (years), median (IQR)1.9 (1.0-3.1)7.5 (3.0-13.6)c9.2 (4.5-14.0)1.0 (0.7-1.6)c1.1 (0.7-1.8)9.3 (4.7-14.0)c
Sex, male31 (55.4)103 (44.2)90 (43.1)44 (55.0)46 (53.5)88 (43.4)
Weight (kg), median (IQR)11.2 ± 5.226.7 ± 17.5c29.2 ± 16.79.6 ± 6.1c10.1 ± 9.229.6 ± 16.8c
Comorbidities, yes13 (23.2)24 (10.3)a29 (13.9)8 (10.0)8 (9.3)29 (14.3)
Presence of cerebral palsy, yes6 (10.7)7 (3.0%)a12 (5.7)1 (1.3)1 (1.2)12 (5.9)
Type of surgery
Orthopedic14 (25.0)120 (51.5)b126 (60.3)8 (10.0)c12 (14.0)122 (60.1)c
Abdominal26 (46.4)65 (27.9)54 (25.8)37 (46.3)39 (45.3)52 (25.6)
Other16 (28.6)48 (20.6)29 (13.9)35 (43.7)35 (40.7)29 (14.3)
LOS in ICU (days), median (IQR)3 (2-4.5)2 (2-3)c2 (2-3)3 (2-4)c3 (2-4)2 (2-3)c
Hospital LOS, mean ± SD16.3 ± 6.915.9 ± 6.415.4 ± 6.317.4 ± 6.7a17.4 ± 6.615.4 ± 6.3a
RASS, mean ± SD1.3 ± 0.41.0 ± 0.1c1.1 ± 0.41.1 ± 0.31.1 ± 0.31.1 ± 0.4
Table 3 Univariate and multivariate logistic regression models investigating associations of parental care with prescriptions for sedation therapy among pediatric intensive care units patients
VariablesDiazepam
Trimeperidine
Morphine
Unadj. OR
(95%CI)
Adj. OR (95%CI)
Unadj. OR (95%CI)
Adj. OR (95%CI)
Unadj. OR (95%CI)
Adj. OR (95%CI)
Parental care0.28 (0.14-0.56)c0.11 (0.05-0.25)c0.43 (0.25-0.72)b0.73 (0.33-1.61)2.69 (1.61-4.50)c1.84 (0.88-3.84)
Age0.75 (0.68-0.83)c0.66 (0.56-0.77)c2.57 (1.94-3.40)c2.22 (1.69-2.92)c0.47 (0.38-0.59)c0.52 (0.41-0.64)c
Sex, female0.64 (0.36-1.15)0.86 (0.40-1.83)1.61 (0.96-2.70)0.93 (0.41-2.13)0.67 (0.40-1.10)1.12 (0.52-2.41)
Cerebral palsy3.89 (1.30-11.6)a21.0 (3.4-129.1)b3.35 (0.60-18.6)1.77 (0.02-147.2)0.27 (0.05-1.49)0.42 (0.01-13.9)